Early molecular signature of Parkinson and dementia years before the diseases appear

NMR metabolomics could identify altered lipoprotein and protein glycosylation profiles in REM sleep behavior disorder (iRBD), the prodromal stage of Lewy-type synucleinopathies (LTS) -including Parkinson and dementia. NMR showed predictive power distinguishing future clinical outcome, being a useful tool for identifying short-term high-risk patients for conversion to parkinsonism or dementia. Here you can see the […]

GlycA as a new biomarker in rheumatoid arthritis

The research group in Immunology at the University of Oviedo with the participation of Dr. Javier Rodríguez-Carrio has published a study in which one of the variables from our glycoprotein test has been identified as an emerging biomarker for stratification and decision-making in early-stage rheumatoid arthritis. If you want to know more about this publication, […]

We are virtually at the European Arteriosclerosis Society congress

This week the 88th edition of the Congress of the European Arteriosclerosis Society was held in virtual format. The congress has included a large number of basic and clinical research presentations by members of the scientific community. Our research team has participated with the presentation of two Science at a Glance and a poster in […]